2020
DOI: 10.1016/s0169-5002(20)30132-x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical frailty in advanced lung cancer patients: an opportunity to improve outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Over 1000 patients have been screened since then with about 40% being vulnerable or frail (CFS 4+). Frailty correlated with ageing (p < 0.01) and a worse ECOG PS (p < 0.01) [24]. These patients were also 20%-30% less likely to be offered systemic anticancer treatment and less likely to continue beyond one cycle of treatment with more admissions.…”
Section: Manchestermentioning
confidence: 96%
“…Over 1000 patients have been screened since then with about 40% being vulnerable or frail (CFS 4+). Frailty correlated with ageing (p < 0.01) and a worse ECOG PS (p < 0.01) [24]. These patients were also 20%-30% less likely to be offered systemic anticancer treatment and less likely to continue beyond one cycle of treatment with more admissions.…”
Section: Manchestermentioning
confidence: 96%
“…Many sites developed case studies to share project outcomes, and a number have shared learning at national specialty conferences and published their projects in specialty journals. 5,[30][31][32][33]…”
Section: Developing Whole System Approaches To Frailtymentioning
confidence: 99%